A new Commentary in the peer-reviewed OMICS: A Journal of Integrative Biology analyzes Romania's landmark law, the first globally, acknowledging the right of citizens and patients to personalized medicine. Click here to read the article now.
"We suggest that this pioneering legislation paves the way for integrating personalized medicine into Romania's health care system, shaping clinical practice, research, and health policy," state Marius Geanta, MD, from the Centre for Innovation in Medicine, and coauthors. "It marks a significant step in redefining health care delivery, emphasizing individual treatment and the political determinants of personalized medicine, and setting a precedent for future health care innovations worldwide."
The law complements the patient rights law and recognizes that "personalized medicine refers to healthcare provided based on a medical model that utilizes the characterization of individuals' phenotypes and genotypes. This involves offering preventive, diagnostic, curative, rehabilitative, and specific end-of-life care services tailored to each patient."
"The new law is poised to shape current thinking on global governance for genomics, proteomics, metabolomics, artificial intelligence, and other technologies of relevance to personalized/precision medicine and planetary health," says Vural Özdemir, MD, PhD, DABCP, MA, Editor-in-Chief of OMICS.
About the Journal
OMICS: A Journal of Integrative Biology is an authoritative and highly innovative peer-reviewed interdisciplinary journal published monthly online, addressing the latest advances at the intersection of postgenomics medicine, biotechnology and global society, including the integration of multi-omics knowledge, data analyses and modeling, and applications of high-throughput approaches to study complex biological and societal problems. Public policy, governance and societal aspects of the large-scale biology and 21st century data-enabled sciences are also peer-reviewed. Complete tables of content and a sample issue may be viewed on the OMICS: A Journal of Integrative Biology website.
About the Publisher
Mary Ann Liebert, Inc., publishers is known for establishing authoritative peer-reviewed journals in many areas of science and biomedical research. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 90 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.
